A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia-Reference-Cited by-同舟云学术

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia

Published:2020-05 Issue: Volume:193 Page:112232
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Sellmer Andreas,Pilsl Bernadette,Beyer Mandy,Pongratz Herwig,Wirth Lukas,Elz Sigurd,Dove Stefan,Henninger Sven Julian,Spiekermann Karsten,Polzer Harald,Klaeger Susan,Kuster Bernhard,Böhmer Frank D.,Fiebig Heinz-Herbert,Krämer Oliver H.,Mahboobi Siavosh^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference73 articles.

1. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel;Creutzig;Blood,2012

2. FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia;Leung;Leukemia,2013

3. Drug therapy for acute myeloid leukemia;Tallman;Blood,2005

4. Class III receptor tyrosine kinases in acute leukemia - biological functions and modern laboratory analysis;Berenstein;Biomark. Insights,2015

5. Design, synthesis and biological evaluation of FLT3 covalent inhibitors with a resorcylic acid core;Xu;Bioorg. Med. Chem.,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment;Current Medicinal Chemistry;2024-09

2. Inhibitors of the tyrosine kinases FMS-like tyrosine kinase-3 and WEE1 induce apoptosis and DNA damage synergistically in acute myeloid leukemia cells;Biomedicine & Pharmacotherapy;2024-08

3. Targeting hematological malignancies with isoxazole derivatives;Drug Discovery Today;2024-08

4. 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling;European Journal of Medicinal Chemistry;2023-10

5. Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3;Leukemia;2023-09-21